Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

E Gur

Showing results (781-790 of 834) with videos related to

Pageof 84
Sort By:
Molecular Psychiatry|May 5, 2023
Psychosis brain subtypes validated in first-episode cohorts and related to illness remission: results from the PHENOM consortiumDominic B Dwyer, Ganesh B Chand, Alessandro Pigoni, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2025
A Translational Neuroscience & Computational Evaluation of a D1R Partial Agonist for Schizophrenia (TRANSCENDS): Rationale and Study Design of a Brain-Based Clinical TrialClara Fonteneau, Zailyn Tamayo, Ally Price, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
An open, fully-processed data resource for studying mood and sleep variability in the developing brainJuliette B H Brook, Taylor Salo, Audrey C Luo, et al.
American Journal of Medical Genetics. Part A|November 1, 2018
What is new with 22q? An update from the 22q and You Center at the Children's Hospital of PhiladelphiaIan M Campbell, Sarah E Sheppard, T Blaine Crowley, et al.
Schizophrenia Research|May 14, 2020
Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefitScott W Woods, Carrie E Bearden, Fred W Sabb, et al.
Aperture Neuro|June 17, 2026
An open, fully-processed data resource for studying mood and sleep variability in the developing brainJuliette B H Brook, Taylor Salo, Audrey C Luo, et al.
Journal of Psychiatric Research|January 10, 2026
A translational neuroscience & computational evaluation of a D1R partial agonist for schizophrenia (TRANSCENDS): Rationale and study design of a brain-based clinical trialClara Fonteneau, Zailyn Tamayo, Ally Price, et al.
American Journal of Medical Genetics. Part A|October 6, 2018
Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjectsYingjie Zhao, Tingwei Guo, Ania Fiksinski, et al.
Nature Methods|June 22, 2021
QSIPrep: an integrative platform for preprocessing and reconstructing diffusion MRI dataMatthew Cieslak, Philip A Cook, Xiaosong He, et al.
Nature Medicine|November 10, 2020
Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndromeRobert W Davies, Ania M Fiksinski, Elemi J Breetvelt, et al.
Pageof 84

Showing results (781-790 of 834) with videos related to

Sort By:
Pageof 84
Molecular Psychiatry|May 5, 2023
Psychosis brain subtypes validated in first-episode cohorts and related to illness remission: results from the PHENOM consortiumDominic B Dwyer, Ganesh B Chand, Alessandro Pigoni, et al.
Medrxiv : the Preprint Server for Health Sciences|May 5, 2025
A Translational Neuroscience & Computational Evaluation of a D1R Partial Agonist for Schizophrenia (TRANSCENDS): Rationale and Study Design of a Brain-Based Clinical TrialClara Fonteneau, Zailyn Tamayo, Ally Price, et al.
Biorxiv : the Preprint Server for Biology|June 4, 2025
An open, fully-processed data resource for studying mood and sleep variability in the developing brainJuliette B H Brook, Taylor Salo, Audrey C Luo, et al.
American Journal of Medical Genetics. Part A|November 1, 2018
What is new with 22q? An update from the 22q and You Center at the Children's Hospital of PhiladelphiaIan M Campbell, Sarah E Sheppard, T Blaine Crowley, et al.
Schizophrenia Research|May 14, 2020
Counterpoint. Early intervention for psychosis risk syndromes: Minimizing risk and maximizing benefitScott W Woods, Carrie E Bearden, Fred W Sabb, et al.
Aperture Neuro|June 17, 2026
An open, fully-processed data resource for studying mood and sleep variability in the developing brainJuliette B H Brook, Taylor Salo, Audrey C Luo, et al.
Journal of Psychiatric Research|January 10, 2026
A translational neuroscience & computational evaluation of a D1R partial agonist for schizophrenia (TRANSCENDS): Rationale and study design of a brain-based clinical trialClara Fonteneau, Zailyn Tamayo, Ally Price, et al.
American Journal of Medical Genetics. Part A|October 6, 2018
Variance of IQ is partially dependent on deletion type among 1,427 22q11.2 deletion syndrome subjectsYingjie Zhao, Tingwei Guo, Ania Fiksinski, et al.
Nature Methods|June 22, 2021
QSIPrep: an integrative platform for preprocessing and reconstructing diffusion MRI dataMatthew Cieslak, Philip A Cook, Xiaosong He, et al.
Nature Medicine|November 10, 2020
Using common genetic variation to examine phenotypic expression and risk prediction in 22q11.2 deletion syndromeRobert W Davies, Ania M Fiksinski, Elemi J Breetvelt, et al.
Pageof 84